Role of hypoxia-activated prodrugs in combination with radiation therapy: An in silico approach
Tumour hypoxia has been associated with increased resistance to various cancer treatments, particularly radiation therapy. Conversely, tumour hypoxia is a validated and ideal target for guided cancer drug delivery. For this reason, hypoxia-activated prodrugs (HAPs) have been developed, which remain...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2019-07-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/10.3934/mbe.2019312?viewType=HTML |